Vevorisertib (ARQ 751) is an orally active, potent and selective pan-AKT serine/threonine kinase inhibitor with inhibitory effects on AKT1/AKT2/AKT3 and is commonly used in the study of solid tumors with PIK3CA/AKT/PTEN mutations, showing dose-dependent antitumor activity.
Molecular Weight:
586.73
Purity:
98.88%
CAS Number:
[1416775-46-6]
Formula:
C35H38N8O
Target:
Serine Protease|||Akt
T38847
T38847
* VAT and and shipping costs not included. Errors and price changes excepted